About this Research Topic
Nanomaterials have generated significant interest to improve diverse disease therapy. However, conventional nanocarriers in general lack specificity and have poor biodistribution, resulting in low efficacy in desired disease therapy. To avoid this problem, there has been an increasing focus on cell membrane-coated nanocarriers (CMCNCs), which can deliver therapeutics directly to the cells of interest by their unique source cell mimicking properties.
CMCNCs comprise active cell surface proteo-lipid molecules with other functional proteins and offer extended blood circulation with robust cell-specific targeting, guaranteeing enhanced tissue penetration and higher target-specific accumulation of nanocarriers.
In recent years, this field of CMCNCs has been expanding, especially with hard to cure diseases such as cancer, myocardial infarction, and so on. To this end, we welcome contributions of Reviews and Original Research papers reporting recent efforts in the development of cell membrane-coated nanocarriers (CMCNCs) and their application in diverse disease diagnoses and therapy.
Potential topics include, but are not limited to:
• Development of cell membrane-coated nanocarriers (CMCNCs) and cell-derived nanovesicles including extracellular vesicles, exosomes, and hybrid nanovesicles.
• Novel techniques in CMCNCs preparation and characterization CMCNCs
• Application of cell membrane coated nanomaterials in cancer diagnosis and therapy.
• Application of cell membrane coated nanomaterials in cardiovascular disease diagnosis and therapy
• Application of cell membrane coated nanomaterials in the treatment of inflammation-related diseases
• Application of cell membrane coated nanomaterials in the field of molecular imaging
CMCNCs comprise active cell surface proteo-lipid molecules with other functional proteins and offer extended blood circulation with robust cell-specific targeting, guaranteeing enhanced tissue penetration and higher target-specific accumulation of nanocarriers.
In recent years, this field of CMCNCs has been expanding, especially with hard to cure diseases such as cancer, myocardial infarction, and so on. To this end, we welcome contributions of Reviews and Original Research papers reporting recent efforts in the development of cell membrane-coated nanocarriers (CMCNCs) and their application in diverse disease diagnoses and therapy.
Potential topics include, but are not limited to:
• Development of cell membrane-coated nanocarriers (CMCNCs) and cell-derived nanovesicles including extracellular vesicles, exosomes, and hybrid nanovesicles.
• Novel techniques in CMCNCs preparation and characterization CMCNCs
• Application of cell membrane coated nanomaterials in cancer diagnosis and therapy.
• Application of cell membrane coated nanomaterials in cardiovascular disease diagnosis and therapy
• Application of cell membrane coated nanomaterials in the treatment of inflammation-related diseases
• Application of cell membrane coated nanomaterials in the field of molecular imaging
Keywords: nanomaterials, nanoparticles, drug delivery
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
